Bekzod Ibodov

2 ta ish

Tashkent Medical Academy, Neurology, Tashkent, Uzbekistan

1. MCP-1: The role of a novel biomarker in assessing neuroinflammation in Parkinson’s disease and Parkinson-plus syndromes

   D. Akramova, G. Rakhimbaeva, Turdikul Bobomuratov +2

   MaqolaNeuroinflammation and Neurodegeneration MechanismsJournal of the Neurological Sciences20250 iqtibos

   ABIABI:AkademIndex/openalex/2025.article.018146

2. Association between serum Mcp-1 levels and motor impairment severity in Parkinson’s disease and Parkinson-plus syndromes

   D. Akramova, G. Rakhimbaeva, Turdikul Bobomuratov +2

   MaqolaParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences20250 iqtibos

   ABIABI:AkademIndex/openalex/2025.article.018172